<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163209">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02013596</url>
  </required_header>
  <id_info>
    <org_study_id>XJH-A-2013-08-2</org_study_id>
    <nct_id>NCT02013596</nct_id>
  </id_info>
  <brief_title>Transcutaneous Electrical Acupoint Stimulation(TEAS) for Hepatic and Renal Dysfunction After Pneumoperitoneum</brief_title>
  <official_title>Effect of Transcutaneous Electrical Acupoint Stimulation(TEAS) on the Hepatic and Renal Function Impaired by Pneumoperitoneum: a Prospective, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhihong LU</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fourth Military Medical University</source>
  <oversight_info>
    <authority>China: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effect of TEAS pretreatment and treatment on
      hepatic and renal dysfunction induced by pneumoperitoneum in patients undergoing
      laparoscopic surgeries.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients were randomly assigned to three groups, control group and two intervention groups,
      receiving TEAS before and after general anesthesia induction respectively. TEAS was given
      through electrodes attached to acupoints. The time for TEAS was 30min. Venous blood samples
      were collected before and  20min after pneumoperitoneum. Hepatic and renal function index
      including AST, ALT, ALP, BUN, Cr were measured.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Incidence of renal or hepatic dysfunction</measure>
    <time_frame>20min after pneumoperitoneum</time_frame>
    <safety_issue>No</safety_issue>
    <description>percentage of patients with renal or hepatic dysfunction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of hepatic function</measure>
    <time_frame>20min after pneumoperitoneum</time_frame>
    <safety_issue>No</safety_issue>
    <description>the increase of hepatic ALT and AST after pneumoperitoneum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of renal function</measure>
    <time_frame>20min after pneumoperitoneum</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change of BUN and Cr after pneumoperitoneum</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hepatic Dysfunction Transient</condition>
  <condition>Renal Function Disorder</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients were given no TEAS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TEAS Pretreatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients were given 30min of TEAS before pneumoperitoneum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TEAS Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients were given 30min of TEAS during pneumoperitoneum</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TEAS pretreatment</intervention_name>
    <description>Electric stimulation was given through electrode attached to specific acupoints for 30mins before anesthesia induction</description>
    <arm_group_label>TEAS Pretreatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TEAS treatment</intervention_name>
    <description>Transcutaneous Electrical Acupoint Stimulation was given to the patient at the same time of the start of anesthesia induction for 30mins</description>
    <arm_group_label>TEAS Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt;18yrs,&lt;60yrs；

          -  ASA  1-2；

          -  Scheduled for laparoscopic surgery under general anesthesia；

          -  Informed consented

        Exclusion Criteria:

          -  Patients with hepatic or renal dysfunction；

          -  Patients with severe hypertension or cardiac dysfunction；

          -  Patients with severe pulmonary disease；

          -  Patients with hemoglobin&lt;100g/L
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>zhihong Lu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xijing hospital, Fourth military medical university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hailong Dong, MD</last_name>
    <phone>86-29-84775337</phone>
    <email>hldong9@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xijing Hospital, Fourth Military Medical University</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lize XIONG, MD</last_name>
      <phone>86-29-84775001</phone>
      <email>mzkxlz@126.com</email>
    </contact>
    <investigator>
      <last_name>Zhihong LU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Westgarth-Taylor C, de Lijster L, van Bogerijen G, Millar AJ, Karpelowsky J. A prospective assessment of renal oxygenation in children undergoing laparoscopy using near-infrared spectroscopy. Surg Endosc. 2013 Oct;27(10):3696-704. doi: 10.1007/s00464-013-2950-3. Epub 2013 Apr 19.</citation>
    <PMID>23605192</PMID>
  </reference>
  <reference>
    <citation>de Barros RF, Miranda ML, de Mattos AC, Gontijo JA, Silva VR, Iorio B, Bustorff-Silva JM. Kidney safety during surgical pneumoperitoneum: an experimental study in rats. Surg Endosc. 2012 Nov;26(11):3195-200. doi: 10.1007/s00464-012-2322-4. Epub 2012 May 19.</citation>
    <PMID>22609982</PMID>
  </reference>
  <reference>
    <citation>Parikh BK, Shah VR, Modi PR, Butala BP, Parikh GP. Anaesthesia for laparoscopic kidney transplantation: Influence of Trendelenburg position and CO2 pneumoperitoneum on cardiovascular, respiratory and renal function. Indian J Anaesth. 2013 May;57(3):253-8. doi: 10.4103/0019-5049.115607.</citation>
    <PMID>23983283</PMID>
  </reference>
  <reference>
    <citation>Wiesenthal JD, Fazio LM, Perks AE, Blew BD, Mazer D, Hare G, Honey RJ, Pace KT. Effect of pneumoperitoneum on renal tissue oxygenation and blood flow in a rat model. Urology. 2011 Jun;77(6):1508.e9-15. doi: 10.1016/j.urology.2011.02.022. Epub 2011 Apr 19.</citation>
    <PMID>21507469</PMID>
  </reference>
  <reference>
    <citation>Ahn JH, Lim CH, Chung HI, Choi SU, Youn SZ, Lim HJ. Postoperative renal function in patients is unaltered after robotic-assisted radical prostatectomy. Korean J Anesthesiol. 2011 Mar;60(3):192-7. doi: 10.4097/kjae.2011.60.3.192. Epub 2011 Mar 30.</citation>
    <PMID>21490821</PMID>
  </reference>
  <reference>
    <citation>Hoekstra LT, Ruys AT, Milstein DM, van Samkar G, van Berge Henegouwen MI, Heger M, Verheij J, van Gulik TM. Effects of prolonged pneumoperitoneum on hepatic perfusion during laparoscopy. Ann Surg. 2013 Feb;257(2):302-7. doi: 10.1097/SLA.0b013e31825d5b2b.</citation>
    <PMID>22824851</PMID>
  </reference>
  <reference>
    <citation>Eryılmaz HB, Memiş D, Sezer A, Inal MT. The effects of different insufflation pressures on liver functions assessed with LiMON on patients undergoing laparoscopic cholecystectomy. ScientificWorldJournal. 2012;2012:172575. doi: 10.1100/2012/172575. Epub 2012 Apr 24.</citation>
    <PMID>22619616</PMID>
  </reference>
  <reference>
    <citation>Li J, Liu YH, Ye ZY, Liu HN, Ou S, Tian FZ. Two clinically relevant pressures of carbon dioxide pneumoperitoneum cause hepatic injury in a rabbit model. World J Gastroenterol. 2011 Aug 21;17(31):3652-8. doi: 10.3748/wjg.v17.i31.3652.</citation>
    <PMID>21987614</PMID>
  </reference>
  <reference>
    <citation>Jeong GA, Cho GS, Shin EJ, Lee MS, Kim HC, Song OP. Liver function alterations after laparoscopy-assisted gastrectomy for gastric cancer and its clinical significance. World J Gastroenterol. 2011 Jan 21;17(3):372-8. doi: 10.3748/wjg.v17.i3.372.</citation>
    <PMID>21253398</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 6, 2014</lastchanged_date>
  <firstreceived_date>September 16, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Fourth Military Medical University</investigator_affiliation>
    <investigator_full_name>Zhihong LU</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>hepatic dysfunction</keyword>
  <keyword>renal dysfunction</keyword>
  <keyword>pneumoperitoneum</keyword>
  <keyword>Transcutaneous electric stimulation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pneumoperitoneum</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
